Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Samuel M. Ailsworth"'
Autor:
Behnam Keshavarz, Nathan E. Richards, Lisa J. Workman, Jaimin Patel, Lyndsey M. Muehling, Glenda Canderan, Deborah D. Murphy, Savannah G. Brovero, Samuel M. Ailsworth, Will H. Eschenbacher, Emily C. McGowan, Barbara J. Mann, Michael R. Nelson, Alexandra Kadl, Judith A. Woodfolk, Thomas A.E. Platts-Mills, Jeffrey M. Wilson
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Three COVID-19 vaccines have received FDA-authorization and are in use in the United States, but there is limited head-to-head data on the durability of the immune response elicited by these vaccines. Using a quantitative assay we studied binding IgG
Externí odkaz:
https://doaj.org/article/f4a83396663b422295ffe601e519ff3a
Autor:
Samuel M, Ailsworth, Behnam, Keshavarz, Nathan E, Richards, Lisa J, Workman, Deborah D, Murphy, Michael R, Nelson, Thomas A E, Platts-Mills, Jeffrey M, Wilson
Publikováno v:
Annals of Allergy, Asthma & Immunology. 130:67-73
BNT162b2 (Pfizer/BioNTech, Cominarty) and mRNA-1273 (Moderna, Spikevax) are mRNA vaccines that elicit antibodies against the SARS-CoV-2 spike receptor-binding domain (S-RBD) and have been approved by the Food and Drug Administration (FDA) to combat t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf9cf69c8328915f4e09bf6357d7564
https://doi.org/10.1016/j.anai.2022.10.003
https://doi.org/10.1016/j.anai.2022.10.003